Nivolumab with ipilimumab for untreated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency [ID1136] Draft guidance Technology appraisal guidance 3 March ...
Tarlatamab for previously treated advanced small-cell lung cancer [ID6364] Draft guidance Technology appraisal guidance 18 February 2025 Durvalumab with tremelimumab for untreated advanced or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback